Ventrus Biosciences (VTUS)

IPO News
Latest User Comments
Business
  • Specialty pharmaceutical company focused on late-stage drugs for gastrointestinal disorders.
  • Health-Drugs
  • 0
  • 2005
IPO Profile
  • TBA
  • 07/20/10
  • $20.0 mm
  • $0 - $0
  • n/a
  • National Securities

  • All Underwriters
VTUS Daily
Week Month Quarter 1 Year
 
Corporate Data
  • 787 7th Ave, 48th Floor
    New York, NY
  • 212-554-4300
  • www.ventrusbio.com